Drug Study

Rosiglitazone Maleate (Avandia) Drug Study

Rosiglitazone Maleate (Avandia) Drug Study

in Drug Study

Rosiglitazone is a thiazolidinedione antidiabetic agent which improves insulin sensitivity by lowering blood glucose level without increasing pancreatic insulin secretion. It is dependent on the presence of insulin. Rosiglitazone is a potent agonist for the peroxisome proliferator-activated receptor-gamma, which in turn regulates the transcription of insulin-responsive genes involved in the control of glucose production, transport and utilization.

Read more ›
Sucralfate (Carafate) Drug Study

Sucralfate (Carafate) Drug Study

in Drug Study

Sucralfate protects GI lining against peptic acid, pepsin and bile salts by binding with positively-charged proteins in exudates forming a viscous paste-like adhesive substance thus forming a protective coating.

Read more ›
Propranolol HCl (Inderal) Drug Study

Propranolol HCl (Inderal) Drug Study

in Drug Study

Propranolol competitively blocks β1- and β2-receptors resulting to decreased heart rate myocardial contractility, BP and myocardial oxygen demand. It only possesses membrane-stabilising properties.

Read more ›
Spironolactone (Aldactone) Drug Study

Spironolactone (Aldactone) Drug Study

in Drug Study

Spironolactone acts on the distal renal tubules as a competitive antagonist of aldosterone. It increases the excretion of sodium chloride and water while conserving potassium and hydrogen ions.

Read more ›
Zafirlukast (Accolate) Drug Study

Zafirlukast (Accolate) Drug Study

in Drug Study

Generic Name : zafirlukast Brand Name: Accolate Classification: Antasthmatic, Leukotriene receptor antagonist Pregnancy Category B Dosage & Route Available forms : Tablet—10, 20 mg ADULTS AND CHILDREN > 12 YR 20 mg PO bid on an empty stomach. PEDIATRIC PATIENTS 5–11 YR 10 mg PO bid on an empty stomach. Therapeutic actions Zafirlukast selectively antagonizes the leukotriene D4 receptor. It [...]

Read more ›
Warfarin Sodium (Coumadin) Drug Study

Warfarin Sodium (Coumadin) Drug Study

in Drug Study

Warfarin inhibits synthesis of vit K-dependent coagulation factors VII, IX, X and II and anticoagulant protein C and its cofactor protein S. No effects on established thrombus but further extension of the clot can be prevented. Secondary embolic phenomena are avoided.

Read more ›
Verapamil HCl (Verelan) Drug Study

Verapamil HCl (Verelan) Drug Study

in Drug Study

Generic Name : verapamil hydrochloride Brand Name: Apo-Verapamil (CAN), Calan, Calan SR, Covera-HS, Gen-Verapamil (CAN), Gen-Verapamil SR (CAN), Isoptin SR, Novo-Verapamil SR (CAN), Nu-Verap (CAN), Verelan, Verelan PM Classification: Calcium channel-blocker, Antianginal, Antiarrhythmic, Antihypertensive Pregnancy Category C Dosage & Route ADULTS Oral Immediate release Angina: 80 mg q 6–8 hr; may increase by 80 mg at weekly intervals until control [...]

Read more ›
Tramadol HCl (Ultram) Drug Study

Tramadol HCl (Ultram) Drug Study

in Drug Study

Tramadol inhibits reuptake of norepinephrine, serotonin and enhances serotonin release. It alters perception and response to pain by binding to mu-opiate receptors in the CNS.

Read more ›